Muna Bhanji - 28 Apr 2022 Form 3 Insider Report for Intellia Therapeutics, Inc. (NTLA)

Role
Director
Signature
/s/ James Basta, Attorney-in-Fact
Issuer symbol
NTLA
Transactions as of
28 Apr 2022
Net transactions value
$0
Form type
3
Filing time
02 May 2022, 21:48:13 UTC
Previous filing
01 Apr 2022
Next filing
11 May 2022

No securities are beneficially owned.

Remarks:

No Securities are beneficially owned.